Point72 Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Sell |
168,779
-67,227
| -28% | -$921K | ﹤0.01% | 819 |
|
|
2025
Q1 | $2.61M | Sell |
236,006
-81,108
| -26% | -$897K | 0.01% | 762 |
|
|
2024
Q4 | $3.38M | Sell |
317,114
-1,189,532
| -79% | -$12.7M | 0.01% | 729 |
|
|
2024
Q3 | $19.1M | Sell |
1,506,646
-942,631
| -38% | -$12M | 0.05% | 363 |
|
|
2024
Q2 | $41.1M | Buy |
2,449,277
+1,337,257
| +120% | +$22.4M | 0.11% | 232 |
|
|
2024
Q1 | $16.7M | Buy |
1,112,020
+986,020
| +783% | +$14.8M | 0.04% | 462 |
|
|
2023
Q4 | $1.89M | Sell |
126,000
-81,733
| -39% | -$1.23M | ﹤0.01% | 864 |
|
|
2023
Q3 | $2.91M | Buy |
+207,733
| New | +$2.91M | 0.01% | 787 |
|
|
2020
Q1 | – | Sell |
-222,024
| Closed | -$7.41M | – | 1051 |
|
|
2019
Q4 | $7.41M | Buy |
222,024
+164,222
| +284% | +$5.48M | 0.04% | 407 |
|
|
2019
Q3 | $1.38M | Buy |
57,802
+290
| +0.5% | +$6.91K | 0.01% | 588 |
|
|
2019
Q2 | $2.07M | Sell |
57,512
-206,087
| -78% | -$7.41M | 0.01% | 567 |
|
|
2019
Q1 | $9.74M | Buy |
263,599
+198,599
| +306% | +$7.34M | 0.04% | 361 |
|
|
2018
Q4 | $2.8M | Buy |
65,000
+12,954
| +25% | +$558K | 0.01% | 581 |
|
|
2018
Q3 | $2.46M | Buy |
+52,046
| New | +$2.46M | 0.01% | 595 |
|